Cytokine release syndrome in COVID-19 patients, a new scenario for an old concern. The fragile balance between infections and autoimmunity [PDF]
, 2020 On 7 January 2020, researchers isolated and sequenced in China from patients with severe pneumonitis a novel coronavirus, then called SARS-CoV-2, which rapidly spread worldwide, becoming a global health emergency.
Diamanti, A. P. +4 more
core +2 more sources
Early Multi-organ Point-of-Care Ultrasound Evaluation of Respiratory Distress During SARS-CoV-2 Outbreak: Case Report [PDF]
, 2020 Introduction: Coronavirus disease 2019 (COVID-19) is caused by the virus known as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Several case series from Italy and China have highlighted the lung ultrasound findings of this disease ...
Becherer-Bailey, Graham +3 more
core
2019 Novel Coronavirus (COVID-19) Pandemic: Built Environment Considerations To Reduce Transmission. [PDF]
, 2020 With the rapid spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that results in coronavirus disease 2019 (COVID-19), corporate entities, federal, state, county, and city governments, universities, school districts, places of worship,
Coil, David A +5 more
core +2 more sources
Exosomes Derived from Bone Marrow Mesenchymal Stem Cells as Treatment for Severe COVID-19
Stem Cells and Development, 2020 This prospective nonrandomized open-label cohort study addresses the safety and efficacy of exosomes (ExoFlo™) derived from allogeneic bone marrow mesenchymal stem cells as treatment for severe COVID-19.
V. Sengupta +5 more
semanticscholar +1 more source
Persistent Risk of Severe Covid-19 in Heart Transplant Recipients: A National Cohort Study
The Journal of Heart and Lung Transplantation, 2023 Purpose Vaccination and therapeutic monoclonal antibodies (mAb) provide high protection against severe forms of SARS-CoV-2 infection (COVID-19) in the general population.
C. Legeai +6 more
semanticscholar +1 more source
Peripheral neuropathy in severe COVID‐19 resolved with therapeutic plasma exchange
Clinical Case Reports, 2020 Peripheral neuropathies including Guillain‐Barré syndrome may be linked to life‐threatening COVID‐19. Plasma exchange is a safe rescue therapy in severe COVID‐19 with associated neurological manifestations and thromboinflammation.
Fahad Faqihi +5 more
doaj +1 more source
COVID-19 Severity: Lung-Heart Interplay
Current Cardiology Reviews, 2021 Abstract: In December 2019, a novel COVID-19 infection caused by SARS-CoV-2 has emerged as a global emergency. In a few months, the pathogen has infected millions of people in the world. Primarily SARS-CoV-2 infects the pulmonary system which ultimately leads to ARDS and lung failure.
Gayatri Puri +2 more
openaire +2 more sources
Severe acquired hypertriglyceridemia following COVID-19 [PDF]
BMJ Case Reports, 2021 Severe hypertriglyceridemia is a major risk factor for acute pancreatitis. In exceptional cases, it is caused by plasma components inhibiting lipoprotein lipase activity. This phenomenon is predominantly associated with autoimmune diseases. Here, we report a case of severe hypertriglyceridemia due to a transient reduction in lipoprotein lipase activity
Lauré M Fijen +3 more
openaire +3 more sources
Necrotizing pneumonia due to Pseudomonas aeruginosa secondary to severe COVID‐19 pneumonia
Clinical Case Reports, 2023 Necrotizing pneumonia (NP) can occur as a secondary infection even if the clinical course of COVID‐19 pneumonia is favorable, particularly in patients on mechanical ventilation and under immunosuppression.
Jun Hirai +3 more
doaj +1 more source
Comprehensive mapping of immune perturbations associated with severe COVID-19
Science immunology, 2020 Although critical illness has been associated with SARS-CoV-2-induced hyperinflammation, the immune correlates of severe COVID-19 remain unclear. Here, we comprehensively analyzed peripheral blood immune perturbations in 42 SARS-CoV-2 infected and ...
L. Kuri-Cervantes +33 more
semanticscholar +1 more source